Pulmonary Toxicity due to Chemotherapy How is the Risk and Benefit from ZD1839 Treatment against Non-Small Cell Lung Cancer?

Internal Medicine

Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918

Pulmonary Toxicity due to Chemotherapy How is the Risk and Benefit from ZD1839 Treatment against Non-Small Cell Lung Cancer?

Isamu OKAMOTO, Moritaka SuGA

Author information

Keywords: pulmonary toxicity, chemotherapy, gemcitabine, ZD1839 (Iressa)

JOURNAL FREE ACCESS

2003 Volume 42 Issue 10 Pages 926-927

DOI https://doi.org/10.2169/internalmedicine.42.926

Details

Article 1st page

Content from these authors

© The Japanese Society of Internal Medicine

Favorites & Alerts

Related articles

Recently viewed articles

Predecessor

Japanese Journal of Medicine

Top